Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Debt: 2021-2024

Historic Total Debt for Roivant Sciences (ROIV) over the last 3 years, with Jun 2024 value amounting to $203.5 million.

  • Roivant Sciences' Total Debt fell 1.62% to $203.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $203.5 million, marking a year-over-year decrease of 1.62%. This contributed to the annual value of $200.7 million for FY2024, which is 0.01% up from last year.
  • Roivant Sciences' Total Debt amounted to $203.5 million in Q2 2024, which was up 1.40% from $200.7 million recorded in Q1 2024.
  • Over the past 5 years, Roivant Sciences' Total Debt peaked at $217.7 million during Q4 2023, and registered a low of $32.6 million during Q1 2022.
  • In the last 3 years, Roivant Sciences' Total Debt had a median value of $200.7 million in 2023 and averaged $169.3 million.
  • Its Total Debt has fluctuated over the past 5 years, first slumped by 82.13% in 2022, then skyrocketed by 521.22% in 2023.
  • Over the past 4 years, Roivant Sciences' Total Debt (Quarterly) stood at $204.0 million in 2021, then decreased by 4.39% to $195.1 million in 2022, then climbed by 11.59% to $217.7 million in 2023, then decreased by 1.62% to $203.5 million in 2024.
  • Its Total Debt was $203.5 million in Q2 2024, compared to $200.7 million in Q1 2024 and $217.7 million in Q4 2023.